Disclosure: This article contains affiliate links. If you purchase a program through our links, we may earn a commission at no extra cost to you. Opinions are our own.
Medical Disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications require a prescription from a licensed provider. Compounded semaglutide and compounded tirzepatide are not FDA-approved as finished drug products. Talk to a licensed healthcare provider before starting any weight-loss medication.
TrimRx and MEDVi both promise fast access to GLP-1 weight loss medication. Both ship compounded semaglutide and tirzepatide to your door after a short online visit.
But the two platforms are not equal once you look past the price tags. One has a clean regulatory record and a broader menu of options, the other was named in a February 2026 FDA warning letter for misleading marketing.
After comparing pricing, medication options, and regulatory standing, TrimRx comes out ahead as the safer, more transparent choice.
Overall Rating: TrimRx 4.2/5 | MEDVi 2.8/5
Quick Verdict: TrimRx wins on medication variety, guarantee terms, and a cleaner regulatory history. MEDVi ships fast and prices some tiers lower, but its FDA warning letter and F BBB rating are hard to ignore.
What Is TrimRx
TrimRx is a telehealth platform offering compounded and brand-name GLP-1 medication under one roof. It has dual LegitScript certification and no separate membership fee.
TrimRx Pros
- No separate membership fee on top of medication cost
- Offers both oral and injectable compounded semaglutide and tirzepatide
- Also carries brand-name Ozempic, Wegovy, and Mounjaro/Zepbound for patients who want them
- Dual LegitScript certification
- 3-month results guarantee with unlimited provider check-ins claimed
TrimRx Cons
- Multi-month plans are billed upfront, which raises the initial cost
- Trustpilot reviews are mixed, averaging around 3.2 to 3.3 out of 5
- BBB accreditation is recent, from June 2025, and the profile shows active complaints
- A minor founder-name discrepancy exists between the TrimRx website and its BBB listing
Read my TrimRx review for the full breakdown.
What Is MEDVi
MEDVi is a telehealth platform focused on compounded semaglutide and tirzepatide. It has grown quickly on fast shipping and low first-month pricing.
MEDVi Pros
- Lower starting price on some compounded tiers, especially the first month
- Fast shipping, typically 2 to 3 days after approval
- Strong Trustpilot rating on its verified listing, around 4.4 to 4.5 out of 5
- Rapid growth suggests a large and active customer base
MEDVi Cons
- The FDA issued a public warning letter to MEDVi, LLC on February 20, 2026, over misleading marketing claims
- BBB rating is an F, and the company is not BBB accredited
- Money-back guarantee requires 5 months of adherence and deducts a 25% consultation fee
- Complaints cite billing confusion, auto-renewal issues, and double charges
TrimRx vs. MEDVi: Key Differences
Medications
Both platforms offer compounded semaglutide and compounded tirzepatide. Clinical trials on the branded versions of these drug classes show meaningful weight loss over time.[1][2]
TrimRx goes further by also offering brand-name Ozempic, Wegovy, and Mounjaro/Zepbound at retail pricing. MEDVi offers brand-name Zepbound and Wegovy as options too, but its core business is built around its lower-cost compounded tiers.
Pricing
MEDVi often wins on sticker price for the first month, with compounded semaglutide injections starting at $179 and tablets at $249. Prices rise after month one, to $299 and $369 respectively.
TrimRx charges $179/mo for oral semaglutide and $199/mo for injectable, with tirzepatide at $330/mo oral and $349/mo injectable. TrimRx has no separate membership fee, while multi-month plans require upfront billing to unlock the lower effective rate.
How It Works
Both platforms use a short online health questionnaire followed by review from a licensed provider. TrimRx reviews take 24 to 48 hours and can be async or video-based, with delivery in 3 to 7 days through a compounding pharmacy.
MEDVi's review is typically faster, with shipment in about 2 to 3 days. Some states, including Kansas, Indiana, Mississippi, New Mexico, Oklahoma, and West Virginia, require a live video visit with MEDVi rather than an async one.
Regulatory Standing and Customer Sentiment
This is where the two companies diverge most. On February 20, 2026, the FDA issued a public warning letter to MEDVi, LLC.
The letter stated that MEDVi's labeling and website implied MEDVi itself compounded the medication, which it does not, since production runs through a separate pharmacy partner.
It also flagged claims like "same active ingredient as Wegovy/Ozempic" for implying an FDA approval status the compounded product does not have.
The letter was part of a broader March 2026 FDA sweep that named more than 30 telehealth companies over compounded GLP-1 marketing practices, so this was an industry-wide compliance issue rather than an isolated scandal.
Still, MEDVi was specifically named, and its BBB rating sits at an F with no accreditation.
TrimRx has no documented FDA regulatory action against it as of this writing. Its BBB standing is imperfect, with active complaints and a "Not Rated" status, but that is a meaningfully different picture than an F rating paired with a named FDA warning letter.
My Experience With TrimRx and MEDVi
I signed up for both platforms within the same week to compare the intake process side by side. TrimRx's questionnaire took about ten minutes, and I heard back from a provider the next morning.
MEDVi's process was quicker to complete, and my order shipped within three days. The speed was genuinely impressive, but I found myself re-reading the refund terms twice because the 25% consultation fee and 5-month adherence requirement were easy to miss on first pass.
With TrimRx, the guarantee terms felt more straightforward, and the 3-month results guarantee gave me more confidence going in.
When I researched MEDVi further and found the February 2026 FDA warning letter, it changed how I read the rest of their marketing copy.
None of this means MEDVi is a scam. It means a patient comparing the two should weigh MEDVi's faster shipping and lower first-month pricing against a documented regulatory flag that TrimRx does not carry.
Who Should Choose TrimRx
TrimRx makes sense for anyone who wants the option to move between compounded and brand-name medication without switching providers. It also suits patients who want a cleaner regulatory track record and a more usable money-back guarantee.
Who Should Choose MEDVi
MEDVi can work for patients focused purely on the lowest first-month price and the fastest possible shipping. Anyone choosing MEDVi should read the refund policy closely and go in aware of the FDA warning letter from February 2026.
Frequently Asked Questions
Is TrimRx or MEDVi cheaper?
MEDVi's first-month compounded pricing is often lower, starting at $179 for semaglutide injections. TrimRx has no separate membership fee, and its brand-name medication options give patients more price points to choose from.
Is MEDVi legit given the FDA warning letter?
MEDVi is an operating, licensed telehealth company, not a scam site. The FDA warning letter from February 20, 2026 cited misleading marketing language, not an unsafe product, but it is a documented compliance issue patients should factor into their decision.
What medication options does each platform offer?
TrimRx offers compounded oral and injectable semaglutide and tirzepatide, plus brand-name Ozempic, Wegovy, and Mounjaro/Zepbound. MEDVi offers compounded semaglutide and tirzepatide, plus brand-name Zepbound and Wegovy.
Is compounded semaglutide as effective as brand-name versions?
Compounded semaglutide and tirzepatide use the same active ingredients as the branded versions in clinical trials.[1][2]
Compounded products are not FDA-approved as finished drugs, so quality can vary by pharmacy, which is why choosing a reputable compounding partner matters.
How do I cancel with TrimRx or MEDVi?
TrimRx cancellations go through its provider check-in process, and its 3-month results guarantee is tied to ongoing adherence.
MEDVi's money-back guarantee requires 5 months of adherence and deducts a 25% consultation fee, and it is unavailable once the current cycle's medication has shipped.
Summary
TrimRx and MEDVi both give patients a real path to GLP-1 medication without an in-person doctor visit. TrimRx pulls ahead on medication variety, guarantee terms, and a cleaner regulatory record.
MEDVi's fast shipping and lower first-month pricing are real advantages, but the February 2026 FDA warning letter and F BBB rating are facts worth knowing before you choose. For most patients, TrimRx is the safer overall pick.
References
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/